{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:40:57Z","timestamp":1773848457887,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017649","name":"Government of the Hong Kong Special Administrative Region of the People","doi-asserted-by":"publisher","award":["HKU SRFS2021-7S03"],"award-info":[{"award-number":["HKU SRFS2021-7S03"]}],"id":[{"id":"10.13039\/501100017649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017649","name":"Government of the Hong Kong Special Administrative Region of the People","doi-asserted-by":"publisher","award":["T11\\u2013705\/21-N"],"award-info":[{"award-number":["T11\\u2013705\/21-N"]}],"id":[{"id":"10.13039\/501100017649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005407","name":"Hong Kong Health Bureau","doi-asserted-by":"publisher","award":["CID-HKU2\\u201312"],"award-info":[{"award-number":["CID-HKU2\\u201312"]}],"id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vaccine.2025.128058","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T13:09:57Z","timestamp":1764767397000},"page":"128058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Learning from the omicron BA.4\/5 dominance: Strategies for future vaccination preparedness"],"prefix":"10.1016","volume":"71","author":[{"given":"Jialiang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok Fai","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric Ho Yin","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guosheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin John","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128058_bb0005","author":"World Health Organization. Statement on the fifteenth meeting of the IHR"},{"issue":"10","key":"10.1016\/j.vaccine.2025.128058_bb0010","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/infdis\/jiad353","article-title":"SARS-CoV-2 Hybrid Immunity: The Best of Both Worlds","volume":"228","author":"Lasrado","year":"2023","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.vaccine.2025.128058_bb0015","article-title":"Joint Analysis of Vaccination Effectiveness and Antiviral Drug Effectiveness for COVID-19: A Causal Inference Approach","volume":"143, 107012","author":"Cheung","year":"2024","journal-title":"International Journal of Infectious Diseases"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128058_bb0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3201\/eid3001.230414","article-title":"Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong Kong","volume":"30","author":"Cheung","year":"2024","journal-title":"Emerging Infectious Diseases"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128058_bb0025","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/vaccines12091014","article-title":"Assessing the Impact of Primary-Series Infection and Booster Vaccination on Protection against Omicron in Hong Kong: A Population-Based Observational Study","volume":"12","author":"Jiang","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128058_bb0030","article-title":"Joint Analysis of Time-Varying Effect of Vaccine and Antiviral Drug for Preventing Severe Complications and Mortality","volume":"15","author":"Jiang","year":"2025","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vaccine.2025.128058_bb0035","article-title":"Heterologous COVID-19 Vaccine Schedule with Protein-Based Prime (NVX-CoV2373) and mRNA Boost (BNT162b2) Induces Strong Humoral Responses: Results from COV-BOOST Trial","volume":"106576","author":"Janani","year":"2025","journal-title":"The Journal of Infection"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128058_bb0040","first-page":"587","article-title":"SARS-CoV-2-Infection- and Vaccine-Induced Antibody Responses Are Long Lasting with an Initial Waning Phase Followed by a Stabilization Phase","volume":"57","author":"Srivastava","year":"2024","journal-title":"Immunity (Cambridge, Mass.)"},{"key":"10.1016\/j.vaccine.2025.128058_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127067","article-title":"Estimation of Trajectory of COVID-19 Vaccines Effectiveness against Infection","volume":"55","author":"Jiang","year":"2025","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2025.128058_bb0050","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1056\/NEJMoa2118946","article-title":"Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2","volume":"386","author":"Goldberg","year":"2022","journal-title":"The New England Journal of Medicine"},{"issue":"13","key":"10.1016\/j.vaccine.2025.128058_bb0055","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection","volume":"386","author":"Hall","year":"2022","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128058_bb0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/14760584.2025.2485252","article-title":"Protection and Waning of Vaccine-Induced, Natural and Hybrid Immunity to SARS-CoV-2 in Hong Kong","volume":"24","author":"Jiang","year":"2025","journal-title":"Expert Review of Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128058_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa2203965","article-title":"Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections","volume":"387","author":"Altarawneh","year":"2022","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2025.128058_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104734","article-title":"Effects of Previous Infection, Vaccination, and Hybrid Immunity against Symptomatic Alpha, Beta, and Delta SARS-CoV-2 Infections: An Observational Study","volume":"95","author":"Altarawneh","year":"2023","journal-title":"EBioMedicine"},{"issue":"40","key":"10.1016\/j.vaccine.2025.128058_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh0761","article-title":"History of Primary-Series and Booster Vaccination and Protection against Omicron Reinfection","volume":"9","author":"Chemaitelly","year":"2023","journal-title":"Science Advances"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128058_bb0095","article-title":"Protection against SARS-CoV-2 Omicron BA.4\/5 Variant Following Booster Vaccination or Breakthrough Infection in the UK","volume":"14","author":"Wei","year":"2023","journal-title":"Nature Communications"},{"issue":"10260","key":"10.1016\/j.vaccine.2025.128058_bb0100","first-page":"e71","article-title":"Scientific Consensus on the COVID-19 Pandemic: We Need to Act Now","volume":"396","author":"Alwan","year":"2020","journal-title":"The Lancet (British Edition)"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128058_bb0105","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.3390\/v14112519","article-title":"Evolution and Control of COVID-19 Epidemic in Hong Kong","volume":"14","author":"Wong","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.128058_bb0110","series-title":"Anticoagulation, Immortality, and Observations of COVID-19. Research and Practice in Thrombosis and Haemostasis","first-page":"674","volume":"4, no. 5","author":"Maley","year":"2020"},{"issue":"17","key":"10.1016\/j.vaccine.2025.128058_bb0115","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/sim.7319","article-title":"Semiparametric Estimation of Time-varying Intervention Effects Using Recurrent Event Data","volume":"36","author":"Xu","year":"2017","journal-title":"Statistics in Medicine"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128058_bb0120","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/sim.10049","article-title":"Estimation of Trajectory of Protective Efficacy in Infectious Disease Prevention Trials Using Recurrent Event Times","volume":"43","author":"Cheung","year":"2024","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128058_bb0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression Models and Life-Tables","volume":"34","author":"Cox","year":"1972","journal-title":"Journal of the Royal Statistical Society: Series B (Methodological)"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128058_bb0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41422-023-00781-8","article-title":"Repeated Vaccination of Inactivated SARS-CoV-2 Vaccine Dampens Neutralizing Antibodies against Omicron Variants in Breakthrough Infection","volume":"33","author":"Gao","year":"2023","journal-title":"Cell Research"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128058_bb0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10985-007-9048-y","article-title":"On the Breslow Estimator","volume":"13","author":"Lin","year":"2007","journal-title":"Lifetime Data Analysis"},{"issue":"10","key":"10.1016\/j.vaccine.2025.128058_bb0140","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128058_bb0145","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1016\/S2214-109X(22)00112-7","article-title":"Effectiveness of Homologous and Heterologous Booster Doses for an Inactivated SARS-CoV-2 Vaccine: A Large-Scale Prospective Cohort Study","volume":"10","author":"Jara","year":"2022","journal-title":"The Lancet Global Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128058_bb0150","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1080\/22221751.2022.2072773","article-title":"Real-World Effectiveness of Homologous and Heterologous BNT162b2, CoronaVac, and AZD1222 Booster Vaccination against Delta and Omicron SARS-CoV-2 Infection","volume":"11","author":"Suah","year":"2022","journal-title":"Emerging Microbes & Infections"},{"issue":"8","key":"10.1016\/j.vaccine.2025.128058_bb0155","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJMc2215471","article-title":"Effectiveness of Bivalent Boosters against Severe Omicron Infection","volume":"388","author":"Lin","year":"2023","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128058_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106261","article-title":"Comparative Effectiveness of Bivalent BA.4\u20135 or BA.1 mRNA Booster Vaccines among Immunocompromised Individuals across Three Nordic Countries: A Nationwide Cohort Study","volume":"89","author":"Gram","year":"2024","journal-title":"The Journal of Infection"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128058_bb0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(22)00578-3","article-title":"Protection against Omicron (B.1.1.529) BA.2 Reinfection Conferred by Primary Omicron BA.1 or Pre-Omicron SARS-CoV-2 Infection among Health-Care Workers with and without mRNA Vaccination: A Test-Negative Case-Control Study","volume":"23","author":"Carazo","year":"2023","journal-title":"The Lancet Infectious Diseases"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25013568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:59:40Z","timestamp":1773827980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25013568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"alternative-id":["S0264410X25013568"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Learning from the omicron BA.4\/5 dominance: Strategies for future vaccination preparedness","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128058"}}